These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1382769)

  • 1. Pregnancy associated plasma protein A in Down's syndrome.
    Cuckle H; Lilford RJ; Teisner B; Holding S; Chard T; Grudzinskas JG
    BMJ; 1992 Aug; 305(6850):425. PubMed ID: 1382769
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy associated plasma protein A in Down's syndrome.
    Macintosh MC; Chard T
    BMJ; 1992 Aug; 305(6850):425. PubMed ID: 1382770
    [No Abstract]   [Full Text] [Related]  

  • 3. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.
    Wald N; Stone R; Cuckle HS; Grudzinskas JG; Barkai G; Brambati B; Teisner B; Fuhrmann W
    BMJ; 1992 Jul; 305(6844):28. PubMed ID: 1379094
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlations between first and second trimester markers for Down's syndrome screening.
    Campogrande M; Viora E; Errante G; Bastonero S; Sciarrone A; Grassi Pirrone P; Perona M; Mancini G; Dall'Amico D; Pavanello E; Guaraldo V
    J Med Screen; 2001; 8(3):163-4. PubMed ID: 11678558
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive test for Down's syndrome.
    Pract Midwife; 2015 May; 18(5):10. PubMed ID: 26336776
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnancy-associated plasma protein A (PAPP-A), a first-trimester screening test for Down syndrome and other chromosomal anomalies.
    Brambati B; Macintosh MC; Shrimanker K; Chard T; Grudzinskas JG
    Prenat Diagn; 1994 Sep; 14(9):899-900. PubMed ID: 7531330
    [No Abstract]   [Full Text] [Related]  

  • 9. Will PAPP-A be a biochemical marker for screening of Down's syndrome in the first trimester?
    el Farra K; Grudzinskas JG
    Early Pregnancy; 1995 Mar; 1(1):4-12. PubMed ID: 9363230
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy.
    Odibo A
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1173-4. PubMed ID: 8917014
    [No Abstract]   [Full Text] [Related]  

  • 12. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome--too many choices?
    Mennuti MT; Driscoll DA
    N Engl J Med; 2003 Oct; 349(15):1471-3. PubMed ID: 14534341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prenatal screening for Down's syndrome].
    Qin Q; Christiansen M; Norgaard-Pedersen B
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
    [No Abstract]   [Full Text] [Related]  

  • 15. [First trimester ultrasound screening for nuchal translucency as marker of Down's syndrome].
    Herman A; Maymon R; Dreazen E; Bukovsky I; Weinraub Z
    Harefuah; 1997 Jan; 132(2):94-100. PubMed ID: 9119309
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal cytogenetic screening.
    Simpson JL
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
    [No Abstract]   [Full Text] [Related]  

  • 17. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated screening for Down's syndrome.
    Chen FM
    J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
    [No Abstract]   [Full Text] [Related]  

  • 19. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to: Wald, N.J., Hackshaw, A.K. (1997). Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome, Prenat. Diagn., 17, 821-829.
    Reynolds TM; Dunstan F; Nix B; Williams K; Crossley J; Holding S; Krantz D; Wright D; Bray I; Spencer K
    Prenat Diagn; 1998 May; 18(5):511-9. PubMed ID: 9621388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.